ea0081p177 | Pituitary and Neuroendocrinology | ECE2022
Opalinska Marta
, Sowa-Staszczak Anna
, Kania-Kuc Adrian
, Al Maraih Ibraheem
, Gilis-Januszewska Aleksandra
, Hubalewska-Dydejczyk Alicja
Background: PRRT is an effective treatment option (especially for controlling disease progression)for disseminated neuroendocrine tumors (NETs), with good expression of the somatostatin receptors. Despite significant progress in NET personalized management, searching for novel predictive and prognostic factors of response to PRRT is crucial for more effective follow-up, better treatment choices leading to more favorable final outcome. Some recent studies indicate that the resp...